ArticleCost effectiveness and resource allocation : C/E2009

Cost-effectiveness model comparing olanzapine and other oral atypical antipsychotics in the treatment of schizophrenia in the United States.

Nicolas M Furiak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.